You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Rifampicin-sensitive pulmonary tuberculosis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tuberculosis Trial (GSK3036656, Bedaquiline, Delamanid)

Recruiting
  • Tuberculosis
  • Cape Town, South Africa
    GSK Investigational Site
Jan 24, 2023

Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Bedaquiline,

Completed
  • Tuberculosis, Pulmonary
  • +4 more
  • Rio de Janeiro, Brazil
  • +25 more
Jun 23, 2022

Pulmonary Tuberculosis, Other Specified Pulmonary Tuberculosis Trial in Worldwide (Sutezolid, Rifampicin, Isoniazid)

Recruiting
  • Pulmonary Tuberculosis
  • Other Specified Pulmonary Tuberculosis
  • Lambaréné, Gabon
  • +7 more
Apr 17, 2023

Pulmonary Tuberculosis Trial (Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS), Pretomanid, Bedaquiline, OPC-167832, and

Not yet recruiting
  • Pulmonary Tuberculosis
  • Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS)
  • +3 more
  • (no location specified)
Jul 25, 2023

Tuberculosis, Pulmonary Trial (Optimised dose rifampicin, Standard dose rifampicin)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • Optimised dose rifampicin
  • Standard dose rifampicin
  • (no location specified)
Sep 26, 2023

Rifampicin Susceptible Pulmonary Tuberculosis Trial in Cape Town (RESP301, HRZE)

Not yet recruiting
  • Rifampicin Susceptible Pulmonary Tuberculosis
  • Cape Town, Bellville, South Africa
    TASK Clinical Research Centre
Sep 11, 2023

Tuberculosis, Pulmonary Trial in China (Short Regimen with Rifapentine 10mg/kg, Standardized Regimen, Short Regimen with

Not yet recruiting
  • Tuberculosis, Pulmonary
  • Short Regimen with Rifapentine 10mg/kg
  • +3 more
  • Guiyang, Guizhou, China
  • +5 more
May 28, 2022

Pulmonary TB, Pulmonary Tuberculosis, Drug Sensitive Tuberculosis Trial in Worldwide (TBAJ-876, Pretomanid, Linezolid)

Not yet recruiting
  • Pulmonary TB
  • +2 more
  • Tbilisi, Georgia
  • +20 more
Sep 22, 2023

Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis Trial in China (Bedaquiline, Delamanid, Contezolid)

Not yet recruiting
  • Pulmonary Tuberculosis
  • Rifampicin-resistant Tuberculosis
  • Beijing, Beijing, China
  • +37 more
Oct 11, 2023

Tuberculosis, Pulmonary, Other Specified Pulmonary Tuberculosis Trial in Cape Town, Mbeya, Mwanza (BTZ-043, Bedaquiline,

Not yet recruiting
  • Tuberculosis, Pulmonary
  • Other Specified Pulmonary Tuberculosis
  • Cape Town, South Africa
  • +3 more
Jun 22, 2023

Pulmonary Tuberculosis Trial in Cape Town (Meropenem 6g IV over 6 hours, Ertapenem 1g IM, Meropenem 3g IV)

Completed
  • Pulmonary Tuberculosis
  • Meropenem 6g IV over 6 hours
  • +9 more
  • Cape Town, Western Cape, South Africa
    TASK Clinical Research Centre
May 31, 2023

Tuberculosis, Human Immunodeficiency Virus Trial (Optimised rifamycin)

Not yet recruiting
  • Tuberculosis
  • Human Immunodeficiency Virus
  • Optimised rifamycin
  • (no location specified)
Oct 8, 2022

Tuberculosis, Pulmonary Trial in Seoul (High-dose rifampicin, Isoniazid, Pyrazinamide)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • High-dose rifampicin
  • +4 more
  • Seoul, Korea, Republic of
    Division of Pulmonology and Critical Care Medicine, Department o
Jul 21, 2020

Tuberculosis, Pulmonary Trial in Cape Town (Sanfetrinem Cilexetil, Amoxicillin/clavulanic acid, Rifampicin)

Recruiting
  • Tuberculosis, Pulmonary
  • Sanfetrinem Cilexetil
  • +2 more
  • Cape Town, Western Cape, South Africa
    TASK Clinical Research Centre
May 19, 2022

Rifampicin-resistant Tuberculosis Trial in Beijing (Sudapyridine, Bedaquiline)

Enrolling by invitation
  • Rifampicin-resistant Tuberculosis
  • Beijing, Beijing, China
    Beijing Chest Hospital affiliated to Capital Medical University
Apr 21, 2023

Tuberculosis Trial in Cape Town (GSK3036656, RIFAFOUR e-275)

Completed
  • Tuberculosis
  • Cape Town, South Africa
    GSK Investigational Site
Dec 30, 2021

Pulmonary Tuberculoses, Other Specified Pulmonary Tuberculosis Trial in Cape Town (BTZ-043, Rifafour e-275®, Probe Drug

Completed
  • Pulmonary Tuberculoses
  • Other Specified Pulmonary Tuberculosis
  • Cape Town, South Africa
  • +1 more
Aug 9, 2022

Rifampicin- and Isoniazid-Susceptible Pulmonary Tuberculosis (TB) Trial in Cape Town (BVL-GSK098 9mg, Ethionamide 250mg,

Not yet recruiting
  • Rifampicin- and Isoniazid-Susceptible Pulmonary Tuberculosis (TB)
  • BVL-GSK098 9mg
  • +3 more
  • Cape Town, Western Cape, South Africa
    TASK Clinical Research Centre
Jul 26, 2022

Tuberculosis, Pulmonary Tuberculosis, HIV Coinfection Trial in Johannesburg (Isoniazid, Rifampicin, Ethambutol)

Recruiting
  • Tuberculosis
  • +2 more
  • Johannesburg, Gauteng, South Africa
    Tembisa Clinical Research Centre-The Aurum Institute
Jun 8, 2022

Pulmonary Tuberculosis, Body Weight Changes, Motor Activity Trial (Rifampicin, Isoniazid, Pyrazinamide)

Completed
Has Results
  • Pulmonary Tuberculosis
  • +2 more
  • (no location specified)
May 23, 2022

Multidrug-resistant Tuberculosis, Pulmonary Tuberculosis, Tuberculosis Trial in Niamey (6EH³R³Z, 6EHRZ)

Recruiting
  • Multidrug-resistant Tuberculosis
  • +3 more
  • Niamey, Niger
    Damien Foundation
Oct 29, 2021

Tuberculosis, Pulmonary Trial in Linköping (rifampicin, pyrazinamide, HRZE)

Recruiting
  • Tuberculosis, Pulmonary
  • Linköping, Sweden
    Linköping University Hospital
Aug 19, 2021

HIV Seropositivity, Tuberculosis, Household Contact Trial in Klerksdorp (Daily rifapentine and isoniazid for 4 weeks, Weekly

Not yet recruiting
  • HIV Seropositivity
  • +2 more
  • Daily rifapentine and isoniazid for 4 weeks
  • Weekly rifapentine and isoniazid for 12 weeks
  • Klerksdorp, North West Province, South Africa
    The Aurum Institute: Gavin J Churchyard Legacy Centre
Jan 31, 2023

Pulmonary Tuberculosis Trial (GSK3036656, BTZ-043, Bedaquiline (B))

Not yet recruiting
  • Pulmonary Tuberculosis
  • (no location specified)
Oct 27, 2023

Pulmonary Tuberculosis Trial in Cape Town (PA-824, Rifampin, Rifabutin)

Completed
  • Pulmonary Tuberculosis
  • Cape Town, South Africa
    University of Cape Town Lung Institute
May 18, 2022